Ventrus Biosciences, Inc
Quick facts
Phase 3 pipeline
- Diltiazem Hydrochloride 2% Cream · Dermatology / Pain Management
Diltiazem is a calcium channel blocker that reduces smooth muscle contraction and improves blood flow when applied topically to affected tissues. - VEN 307 · Ophthalmology
VEN 307 is a topical ophthalmic agent designed to reduce intraocular pressure in glaucoma by enhancing aqueous humor outflow.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: